Insulin Degludec
0 likes
China [CN] Diabetes is a global chronic metabolic disease that requires lifelong treatment. Under the influence of genetic or environmental factors, if pancreatic B cells are unable to secrete insulin or secrete insufficient insulin, it will cause diabetes. In patients with type 1 diabetes, pancreatic islet B cells have been lost and can degrade proteins and fats as alternative energy sources, which can easily lead to ketoacidosis. Patients with type 2 diabetes have insulin resistance in their bodies, and their condition gradually worsens as the function of pancreatic B-cells decreases. Early-stage type 2 diabetes patients mainly receive treatment through exercise, diet control and the combination of oral hypoglycemic drugs. However, as the disease progresses, insulin becomes one of the essential treatment methods for both type 1 and type 2 diabetes. At present, the three main long-acting insulins are glargine, detemir and degludec.
Click enlarge Image